Concerns grow over re-assessment of drug economic effectiveness

Published: 2009-01-20 06:58:00

Updated: 2009-01-20 06:58:00

The Health Insurance Review and Assessment Service plans to evaluate the economic effectiveness of 3,000-odd medicines covered by national health insurance, including leading antihypertensive agents, this year, triggering a concern from the pharmaceutical industry about price cuts.

The highlight of the reform package is to enable the national health insurance to pay for medicines that are no...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.